West Pharmaceutical Services, Inc. Share Price

Equities

WST

US9553061055

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:30:01 27/04/2024 am IST 5-day change 1st Jan Change
360.4 USD -2.10% Intraday chart for West Pharmaceutical Services, Inc. -3.12% +2.36%
Sales 2024 * 3.01B 251B Sales 2025 * 3.28B 274B Capitalization 26.25B 2,189B
Net income 2024 * 567M 47.28B Net income 2025 * 673M 56.11B EV / Sales 2024 * 8.52 x
Net cash position 2024 * 617M 51.42B Net cash position 2025 * 1.27B 106B EV / Sales 2025 * 7.61 x
P/E ratio 2024 *
47.2 x
P/E ratio 2025 *
40.3 x
Employees 10,600
Yield 2024 *
0.27%
Yield 2025 *
0.31%
Free-Float 96.67%
More Fundamentals * Assessed data
Dynamic Chart
Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc CI
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423 MT
Health Care Drops Amid Mixed Earnings -- Health Care Roundup DJ
West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised MT
Transcript : West Pharmaceutical Services, Inc., Q1 2024 Earnings Call, Apr 25, 2024
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400 MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q1 Revenue $695.4M, vs. Street Est of $671.7M MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, vs. Street Est of $1.29 MT
West Pharmaceutical Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
West Pharmaceutical Services, Inc. Reaffirms Earnings Guidance for the Full Year 2024 CI
West Pharmaceutical Services, Inc. Announces Third Quarter 2024 Dividend, Payable on August 7, 2024 CI
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says RE
Transcript : West Pharmaceutical Services, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 09:00 AM
Pacific Edge's Chair to Retire; Shares Fall 3% MT
More news
1 day-2.10%
1 week-3.12%
Current month-8.92%
1 month-7.16%
3 months-0.26%
6 months+10.12%
Current year+2.36%
More quotes
1 week
358.89
Extreme 358.885
394.42
1 month
358.89
Extreme 358.885
397.72
Current year
325.74
Extreme 325.735
413.70
1 year
310.42
Extreme 310.42
415.73
3 years
206.19
Extreme 206.19
475.35
5 years
113.04
Extreme 113.04
475.35
10 years
39.11
Extreme 39.11
475.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 24/15/24
Director of Finance/CFO 55 21/18/21
Chief Tech/Sci/R&D Officer 52 26/18/26
Members of the board TitleAgeSince
Director/Board Member 66 01/11/01
Chief Executive Officer 55 24/15/24
Director/Board Member 63 12/16/12
More insiders
Date Price Change Volume
26/24/26 360.4 -2.10% 603,058
25/24/25 368.2 -4.55% 742,377
24/24/24 385.7 -1.15% 757,268
23/24/23 390.2 +3.96% 427,080
22/24/22 375.4 +0.89% 510,659

Delayed Quote Nyse, April 27, 2024 at 01:30 am IST

More quotes
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - own manufactured products (81.8%); - products manufactured under contract (18.2%). Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
360.4 USD
Average target price
391.6 USD
Spread / Average Target
+8.66%
Consensus